LPL Financial LLC

Position in GNLX — GENELUX Corp

CIK 1403438 FORT MILL, SC

Position in GNLX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$475,149

+$138,670 QoQ

Shares Held

157,857

+13.5% QoQ

Ownership

0.349%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#11

of 72 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

LPL Financial LLC holds $557,763,742 across 203 Biotechnology names. GNLX ranks #101 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	289,111	$143,610,107
2	REGN	Regeneron Pharmaceuticals, Inc.	65,755	$41,000,872
3	ARWR	Arrowhead Pharmaceuticals, Inc.	310,761	$25,330,129
4	ARGX	Argenx SE	19,499	$18,090,587
5	ALNY	Alnylam Pharmaceuticals, Inc.	57,890	$17,426,626
6	HALO	Halozyme Therapeutics, Inc.	203,557	$15,932,406
7	RPRX	Royalty Pharma plc	249,117	$13,967,990
8	INSM	INSMED Inc	128,553	$13,706,320

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$475,149	157,857	+13.5%	Shares	Sole	2026-08-07
2026-03-31	$336,479	139,041	+3.5%	Shares	Sole	2026-05-06
2025-12-31	$585,796	134,357	+22.4%	Shares	Sole	2026-02-11
2025-09-30	$461,063	109,777	+4.7%	Shares	Sole	2025-11-12
2025-06-30	$300,882	104,837	+20.7%	Shares	Sole	2025-08-12
2025-03-31	$234,489	86,848	-7.7%	Shares	Sole	2025-05-07
2024-12-31	$222,179	94,144	+72.3%	Shares	Sole	2025-02-11
2024-09-30	$129,468	54,628	-1.0%	Shares	Sole	2024-11-08
2024-06-30	$107,595	55,177	+20.0%	Shares	Sole	2024-08-07
2024-03-31	$295,535	45,962	+6.3%	Shares	Sole	2024-05-10
2023-12-31	$605,820	43,242	+76.5%	Shares	Sole	2024-02-14
2023-09-30	$600,005	24,500	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.